NCT06797817: Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain
- State
- Not started
- Phase
- Phase 3
- People
- 156 planned
- Started
- 1 Jun 2026
- Primary completion
- 1 Sep 2026
- Arms
- Tributyrin
- Results
- None posted
- 28 Jan 2025: Trial registered